Nicotinamide as an Early Alzheimer's Disease Treatment

NCT03061474 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease
Mild Cognitive Impairment

Interventions

DRUG: Nicotinamide
DRUG: Placebo Comparator

Sponsor

University of California, Irvine